Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MB Research Laboratories is a private U.S.-based contract research organization focused on preclinical toxicology, safety evaluation, and regulatory testing rather than therapeutic drug development. Founded in 1972 and based in Pennsylvania, the company provides GLP-compliant in vivo and in vitro testing services for pharmaceutical, biotechnology, medical device, cosmetics, consumer product, agrochemical, and government clients. Its core offerings include acute and subchronic toxicology, eye and skin irritation testing, sensitization, cytotoxicity, genotoxicity, biocompatibility, and other regulatory-ready studies aligned with OECD, ISO, FDA, EPA, DOT, and related standards. MB Research is particularly notable for its long-standing expertise in alternative and non-animal testing methods, including 3D tissue models and other new approach methodologies used for hazard identification and product safety assessment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MB Research Laboratories.